The information on this page was reviewed and approved by
Maurie Markman, MD, President, Medicine & Science at CTCA.
This page was updated on March 1, 2021.
If you’ve been diagnosed with ovarian cancer or have been told that you may have cancer, staging the cancer to determine your treatment plan is essential. At Cancer Treatment Centers of America®(CTCA), our gynecologic oncologists are trained and experienced in treating all stages of ovarian cancer, and they will work with you to design a care plan that is tailored to your needs and treatment goals.
Our gynecologic oncologists will lead your multidisciplinary care team, managing the many aspects of your treatment, from performing tumor-removal surgery to administering chemotherapy, immunotherapy and/or hormone therapy. Your care team will also tailor your treatment plan based on your individual needs, such as incorporating fertility-preserving options if possible and helping you manage ovarian cancer-related side effects, like fatigue, nausea and neuropathy.
Concerned about your ovarian cancer risk? Take our five-minute risk assessment, and get an action plan based on your answers.
The first-line treatment for ovarian cancer is typically surgery, and may include procedures like radical debulking surgery and robotic techniques. Non-surgical options also may be recommended, including chemotherapy and hormone therapy.
Chemotherapy
For ovarian cancer, chemotherapy is typically delivered orally (by mouth), intravenously (through a vein) or directly into the abdomen through a catheter, in a treatment called intraperitoneal chemotherapy.
Hormone therapy
Hormone therapy deprives ovarian cancer cells of the hormones they need to grow, including estrogen.
Ovarian cortex cryopreservation
Ovarian cortex cryopreservation is the process of freezing ovarian tissue before cancer treatment begins so women may be able to have children later.
Surgery
Surgery is often the first-line treatment for ovarian cancer. Several surgical options may be available to remove ovarian tumors, including fertility-sparing procedures.
Targeted therapy
Targeted therapy drugs called PARP inhibitors, which are designed to stop tumor cells from repairing themselves, are often used to treat ovarian cancer.
Many ovarian cancer patients experience side effects from their disease or its treatment, including gastrointestinal symptoms, sexual function impacts and neuropathy. Our multidisciplinary team of supportive care clinicians will work with you to help you manage these side effects to support your strength, well-being and quality of life before and after treatment. Supportive care therapies for ovarian cancer patients may include:
Every patient has the option of meeting with a registered dietitian.
Learn More
"The day of my surgery, I was a nervous but confident about choosing CTCA. I arrived at CTCA and began to prep for my surgery. The various nurses and doctors came in to greet me and made sure I knew their role during surgery. CTCA was so accommodating and encouraging to us. We never felt rushed. They allowed my support system to make me feel comfortable before I had to go in for surgery. It was clear that I also had a dedicated team of doctors and clinicians who were there to support me. "
Offering clinical trials on new and emerging cancer treatment options.
View our clinical trialsTake our cancer risk management questionnaire to help assess your risk and take control.
Assess your cancer risk
Donate to Gateway for Cancer Research
Make a difference in the fight against cancer by donating to cancer research
Gateway for Cancer Research is a 501(c)(3) non-profit organization. Tax-ID: 73-1386920
